While TGF-β exhibits tumor-suppressive effects in early-stage disease, advanced TNBC often hijacks this pathway for immune suppression and metastasis promotion (Bhola et al., 2013; Hao et al., 2019). The gene discussed is TGFB1; the disease is neoplasm.